Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 128 Lung Neoplasms 49 Breast Neoplasms 24 Head and Neck Neoplasms 21 Adenocarcinoma of Lung 18 Brain Neoplasms 15 Neoplasms 14 Adenocarcinoma, Bronchiolo-Alveolar 11 Squamous Cell Carcinoma of Head and Neck 10 Glioblastoma 9 Esophageal Neoplasms 9 Colorectal Neoplasms 9 Rectal Neoplasms 7 Prostatic Neoplasms 7 Neoplasm Metastasis 7 NSCLC 7 Gliosarcoma 7 Colonic Neoplasms 7 Adenocarcinoma Of Esophagus 7 Ovarian Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Adenocarcinoma 5 Urinary Bladder Neoplasms 4 Central Nervous System Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Skin Neoplasms 3 Respiratory Tract Diseases 3 Kidney Neoplasms 3

Interventions

Cisplatin 13 Etoposide 11 Paclitaxel 8 Cyclophosphamide 7 Carboplatin 7 Ifosfamide 6 etoposide phosphate 5 Granulocyte Colony-Stimulating Factor 5 Gemcitabine 5 pembrolizumab 4 fludarabine 4 Sirolimus 4 Bleomycin 4 fludarabine phosphate 3 Sunitinib 3 Oxaliplatin 3 Mesna 3 Melphalan 3 Filgrastim 3 Drug Therapy 3 Brentuximab Vedotin 3 Bevacizumab 3 Automobiles 3 130-nm albumin-bound paclitaxel 3 tremelimumab 2 sodium thiosulfate 2 ribociclib 2 pralsetinib 2 pegfilgrastim 2 durvalumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms, Germ Cell and Embryonal × Gefitinib × Clear all

NCT00198159 2014-09-19

IUCRO-0021

Indiana University

Phase 2 Terminated

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡